Recent News

Connect with us

521 News Items found
Pictured: Kenneth J. Marians
Gerstner Sloan Kettering Receives Grant from Howard Hughes Medical Institute Initiative

The Howard Hughes Medical Institute (HHMI) announced that Memorial Sloan Kettering Cancer Center's Gerstner Sloan Kettering Graduate School of Biomedical Sciences is one of 23 research institutions to receive a grant as part of HHMI's Med into Grad Initiative.
Experimental Breast Cancer Drug Shows Promise in Aggressive Form of Disease

Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.
Pictured: John Halliday, Neha Bhagwat, Ellen Hukkelhoven, Harold Varmus, & Eric Holland
Geoffrey Beene Graduate Student Fellowships Announced

Three second-year students -- Neha Bhagwat, John Halliday, and Ellen Hukkelhoven -- received Geoffrey Beene Graduate Student Fellowships.
Dinshaw Patel (left) and David Allis
Linking Histones and Cancer

Structural biologists at Memorial Sloan Kettering Cancer Center are collaborating with biochemists and cell biologists at The Rockefeller University to study how cells read genetic instructions imprinted on histones, DNA's packaging proteins.
Two Grayer Fellows Named

Third-year students Nicholas Gauthier and Karen Hunter have been named the first Grayer Fellows at Gerstner Sloan Kettering.
Joan Massagué, PhD
Researchers Find Genetic Key to Breast Cancer's Ability to Survive and Spread

New research led by investigators at Memorial Sloan Kettering Cancer Center sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.
Research Reveals What Drives Lung Cancer's Spread

A new study by researchers at Memorial Sloan Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.
Charles Sawyers (left) and Howard Scher
Advances in Development of New Targeted Therapy for Prostate Cancer Show Promise

A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.
Dinshaw J. Patel
Dinshaw Patel Elected to the National Academy of Sciences

Dinshaw J. Patel, a Member in Sloan Kettering Institute's Structural Biology Program and incumbent of the Abby Rockefeller Mauzé Chair in Experimental Therapeutics, was elected to the National Academy of Sciences at its 146th annual meeting in April.
Jennifer A. Zallen
Jennifer Zallen Selected as Early Career Scientist By Howard Hughes Medical Institute

Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist.